13F Holdings
中文EN

RBOT Vicarious Surgical Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1812173 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY20.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-177.5%
ROA-115.0%
ROIC (approx.)-178.7%
Asset turnover—

Leverage & solvency

Liabilities / assets49.7%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$33.60M$40.16M$47.58M$43.90M$22.06M
SG&A expense$15.20M$21.88M$26.86M$29.71M$13.20M
Operating income-$50.03M-$66.56M-$80.67M-$80.08M-$38.22M
Interest expense——$25,000$200,000$89,000
Pretax income-$50.18M-$63.22M-$71.07M$5.16M-$35.21M
Net income-$50.18M-$63.22M-$71.07M$5.16M-$35.21M
EBITDA-$48.60M-$64.45M-$78.81M-$78.97M-$37.91M
EPS (basic)——-0.490.04-0.36
EPS (diluted)——-0.490.04-0.36
Weighted avg. shares (diluted)6.13M5.89M4.87M127.53M96.69M
Balance sheet
Cash & equivalents$2.57M$9.74M$53.76M$117.14M$174.56M
Short-term investments$7.22M$39.36M$45.35M——
Current assets$11.58M$51.70M$100.95M$120.40M$178.37M
PP&E, net$1.27M$4.48M$6.40M$6.59M$2.25M
Total assets$19.58M$67.72M$119.86M$140.29M$181.68M
Current liabilities$3.90M$7.67M$7.28M$8.39M$6.25M
Long-term debt——$2.00M—$675,000
Total debt——$2.00M—$675,000
Total liabilities$9.74M$21.02M$21.89M$29.25M$98.59M
Shareholders' equity$9.84M$46.70M$97.97M$111.05M$83.09M
Net debt——-$51.76M—-$173.89M
Cash flow statement
Operating cash flow-$45.08M-$49.96M-$62.30M-$61.21M-$33.30M
Capital expenditure$132,000$180,000$1.67M$5.35M$1.29M
Free cash flow-$45.21M-$50.14M-$63.98M-$66.56M-$34.59M
Investing cash flow$32.15M$6.86M-$45.78M-$5.35M-$1.29M
Financing cash flow$5.76M$8,000$44.70M$9.14M$192.16M
Depreciation & amortization$1.43M$2.11M$1.85M$1.11M$316,000
Stock-based compensation$8.13M$11.90M$13.27M$12.26M$3.69M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.